Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cellular prion protein suppresses colitis and colorectal carcinogenesis via modulating inflammatory responses.

Biochimica et biophysica acta. Molecular basis of disease·2026

Same author

Implementing public health emergency operations centres according to an international framework in Ethiopia, Nigeria, and Senegal: Best practices and achievements, 2021.

PLOS global public health·2026

Same author

The octapeptide repeats of prion protein play critical roles in the pathogenesis of prion diseases.

Acta neuropathologica communications·2026

Same author

Controllable Synthesis and Pressure-Induced Luminescence Response of Copper Bromide Hybrids for Latent Fingerprint Recognition, Writable Ink, and White Light-Emitting Diode.

Inorganic chemistry·2026

Same author

Characterization of <i>VQ</i> Gene Family and Its Roles in Anthracnose Stress Responses of <i>Juglans regia</i>.

Plant disease·2026

Same author

International collaborative research and development (R&D) on traditional medicine and its contextual factors: a cross-sectional analysis from 1996 to 2022.

Journal of global health·2026

Same journal

Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.

Pathogens (Basel, Switzerland)·2026

Same journal

Ventilator-Associated Pneumonia (VAP) Prevention Bundle: A Multicenter Cross-Sectional Saudi Study to Assess Knowledge, Adherence, and Perceived Barriers Among ICU Practitioners in Hail Region.

Pathogens (Basel, Switzerland)·2026

Same journal

Anti-<i>Borrelia</i> IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case-Control Study from Northern Türkiye.

Pathogens (Basel, Switzerland)·2026

Same journal

Molecular Characterization of Hemotropic <i>Mycoplasma</i> spp. From Bats (Chiroptera) in the Northern Pantanal, Brazil.

Pathogens (Basel, Switzerland)·2026

Same journal

Characterization of Durum-Einkorn Amphiploids for Introgression of Powdery Mildew Resistance from Einkorn into Common Wheat.

Pathogens (Basel, Switzerland)·2026

Same journal

Human Orthohantavirus Infections: A Narrative Review.

Pathogens (Basel, Switzerland)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: Insight Into Advances in Prion Diseases Research

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

Immunotherapy against Prion Disease.

Yue Ma¹, Jiyan Ma¹

¹Center for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E., Grand Rapids, MI 49503, USA.

Pathogens (Basel, Switzerland)

|March 19, 2020

Summary

This summary is machine-generated.

Immunotherapy offers a promising approach to combat fatal prion diseases, despite current treatment limitations. Further research is crucial to develop effective immunotherapy strategies for these devastating neurodegenerative disorders.

Keywords:

PrP antibody immunotherapy prion disease vaccine

More Related Videos

Detection of Abnormal Prion Protein by Immunohistochemistry

Detection of Abnormal Prion Protein by Immunohistochemistry

Published on: May 5, 2023

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: Insight Into Advances in Prion Diseases Research

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

Detection of Abnormal Prion Protein by Immunohistochemistry

Detection of Abnormal Prion Protein by Immunohistochemistry

Published on: May 5, 2023

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Area of Science:

Neuroscience
Immunology
Infectious Diseases

Background:

Prion diseases are fatal neurodegenerative disorders affecting humans and animals with no current effective therapies.
Understanding of prion disease pathogenesis is advanced due to outbreaks and research models, stimulating therapeutic development.
Immunotherapy is explored as a plausible strategy against prion diseases.

Purpose of the Study:

To review the rationale and previous trials of immunotherapy for prion disease.
To discuss challenges and potential strategies for successful prion disease immunotherapy.
To advocate for further research into immunotherapy for prion disease control and treatment.

Main Methods:

Review of existing literature on prion disease immunotherapy.
Analysis of active and passive immunization trials.
Discussion of hurdles and potential solutions for immunotherapy development.

Main Results:

Immunotherapy is presented as a viable therapeutic option for prion diseases.
Previous immunotherapy trials, including active and passive immunization, have been reviewed.
Strategies to overcome challenges in developing effective prion disease immunotherapies are discussed.

Conclusions:

Immunotherapy is a plausible and practical strategy for treating prion diseases.
Continued research is essential to develop effective immunotherapy measures.
Developing successful immunotherapy could lead to better control of these devastating disorders.